Source: John Hopkins University By: By Lillie Shockney, R.N., M.A.S
February 29, 2008
Scientists from the Dana-Farber Cancer Institute presented some stirring news at the annual meeting of the American Society of Clinical Oncology in June. The researchers, reporting the results of a clinical trial, said that the drug lapatinib (also kn
StarlightRN
about 5 years ago
6394 comments
I found this very interesting and hopeful. I work with alot of patients with breast cancer and it's nice to know that is being advancement made.